KR 31372, a benzopyran derivative, inhibits oxidized LDL-stimulated proliferation and migration of vascular smooth muscle cells

Fundamental and Clinical Pharmacology

Volumn 14, Issue 5, 2000, Pages 469-476

  Hee Kim, Hyun ^a   Joo Ha, Hun ^b   Kim, Sun Ok ^c   Kim, Soo Kyung ^d   Yoo, Sung Eun ^d   Whan Hong, Ki ^a  

^a Pusan National University School of Medicine   (South Korea)

^b Yonsei University   (South Korea)

^c Dongbu Hannong Chemical Co   (South Korea)

^d Korea Research Institute of Chemical Technology   (South Korea)

Author keywords

Antioxidation; K+ channels; KR 31372; Migration; Oxidized LDL; PDGF BB

Indexed keywords

BENZOPYRAN DERIVATIVE; KR 31372; N'' CYANO N (6 NITRO 3,4 DIHYDROHYDROXY 2 METHYL 2 DIMETHOXYMETHYL 2H 1 BENZOPYRAN 4YL) N' BENZYLGUANIDINE; OXIDIZED LOW DENSITY LIPOPROTEIN; PLATELET DERIVED GROWTH FACTOR BB; PROBUCOL; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; DRUG EFFECT; LIPID OXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE;

EID: 0033778245     PISSN: 07673981     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2000.tb00429.x     Document Type: Article

References (27)

1. Oxidized low-density lipoprotein is chemotactic for arterial smooth muscle cells in culture
2. 2 in vascular smooth muscle cells
3. Flow cytometric studies of oxidative product formation by neutrophils: A graded response to membrane stimulation
4. A factor from a transformed cell line that affects cell migration
5. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF
6. Probucol inhibits neointimal thickening and macrophage accumulation after balloon injury in the cholesterol fed rabbit
7. Drug antioxidant effects. A basis for drug selection?
8. Antiperoxidative actions of calcium antagonists and atherogenesis
9. + channel opener, in comparison with levcromakalim
10. Platelet-derived growth factor (PDGF): Actions and mechanisms in vascular smooth muscle
11. Oxidation of plasma low-density lipoprotein accelerates its accumulation and degradation in the arterial wall in vivo
12. SKP-450 inhibits migration and DNA synthesis stimulated by oxidized low density lipoprotein in smooth muscle cells
13. 2+ requirement for optimal lipid peroxidation of low density lipoprotein by activated human monocytes
14. Retardation of angiographic progression of coronary artery disease by nifedipine
15. Potent inhibitory activities of hydrophobic acireductones (2-hydrotetronic acid analogs) against membrane and human low-density lipoprotein oxidation
16. Probucol inhibits oxidative modification of low-density lipoprotein
17. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression
18. A modern view of atherogenesis
19. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity
20. Role of oxidatively modified LDL in atherosclerosis
21. Amlodipine inhibition of serum-, thrombin-, or fibroblast growth factor-induced vascular smooth-muscle cell proliferation
22. Native and oxidized LDL enhances production of PDGF-AA and the surface expression of PDGF receptors in cultured human smooth muscle cells
23. Oxidants as stimulators of signal transduction
24. Protective effects of calcium antagonists in different organs and tissues
25. Protective action of calcium channel antagonists in atherogenesis and experimental vascular injury
26. Oxidation of low density lipoprotein enhances its potential to increase intracellular free calcium concentration in vascular smooth muscle cells
27. Transmembrane calcium flux regulates LDL oxidation by arterial smooth muscle cells